{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:11Z","timestamp":1707524711911},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,10]]},"DOI":"10.7759\/cureus.32388","type":"journal-article","created":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T06:01:01Z","timestamp":1670738461000},"source":"Crossref","is-referenced-by-count":0,"title":["Myeloproliferative Neoplasm and Myelodysplastic Syndrome-Associated Renal Disease: A Histopathological Report of Two Cases"],"prefix":"10.7759","author":[{"given":"Hristo","family":"Popov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Koleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George S","family":"Stoyanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ghenev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Myeloproliferative neoplasms: introduction","author":"Khoury JD","year":"2022","unstructured":"Khoury JD. Myeloproliferative neoplasms: introduction. Haematolymphoid Tumours, 5th Ed (Online version). Hochhaus A (ed): International Agency for Research on Cancer (IARC), Lyon, France; 2022."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2016.263","article-title":"Chronic kidney disease in the BCR-ABL1-negative myeloproliferative neoplasm: a single-center retrospective study","volume":"33","author":"Baek SW","year":"2018","unstructured":"Baek SW, Moon JY, Ryu H, et al.. Chronic kidney disease in the BCR-ABL1-negative myeloproliferative neoplasm: a single-center retrospective study. Korean J Intern Med. 2018, 33:790-7. 10.3904\/kjim.2016.263","journal-title":"Korean J Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2014.01.014","article-title":"Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasms","volume":"38","author":"Christensen AS","year":"2014","unstructured":"Christensen AS, M\u00f8ller JB, Hasselbalch HC. Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasms. Leuk Res. 2014, 38:490-5. 10.1016\/j.leukres.2014.01.014","journal-title":"Leuk Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000168720","article-title":"Nephrotic syndrome associated with agnogenic myeloid metaplasia","volume":"14","author":"Perazella MA","year":"1994","unstructured":"Perazella MA, Buller GK. Nephrotic syndrome associated with agnogenic myeloid metaplasia. Am J Nephrol. 1994, 14:223-5. 10.1159\/000168720","journal-title":"Am J Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70047-8","article-title":"Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders","volume":"34","author":"Au WY","year":"1999","unstructured":"Au WY, Chan KW, Lui SL, Lam CCK, Kwong YL. Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders. Am J Kidney Dis. 1999, 34:889-93. 10.1016\/S0272-6386(99)70047-8","journal-title":"Am J Kidney Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/08860220903573286","article-title":"Focal segmental glomerulosclerosis associated with idiopathic myelofibrosis","volume":"32","author":"Kaygusuz I","year":"2010","unstructured":"Kaygusuz I, Koc M, Arikan H, Adiguzel C, Cakalagaoglu F, Tuglular TF, Akoglu E. Focal segmental glomerulosclerosis associated with idiopathic myelofibrosis. Ren Fail. 2010, 32:273-6. 10.3109\/08860220903573286","journal-title":"Ren Fail"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2013.04.014","article-title":"The myeloproliferative neoplasms-related glomerulopathy (Article in French)","volume":"35","author":"Bardy A","year":"2014","unstructured":"Bardy A, Tiple A, Rabant M, et al.. The myeloproliferative neoplasms-related glomerulopathy (Article in French). Rev Med Interne. 2014, 35:222-30. 10.1016\/j.revmed.2013.04.014","journal-title":"Rev Med Interne"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-223803","article-title":"Focal segmental glomerulosclerosis in a patient with prefibrotic primary myelofibrosis","volume":"2018","author":"Bohra GK","year":"2018","unstructured":"Bohra GK, Meena DS, Bajpai N, Purohit A. Focal segmental glomerulosclerosis in a patient with prefibrotic primary myelofibrosis. BMJ Case Rep. 2018, 2018:10.1136\/bcr-2017-223803","journal-title":"BMJ Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5414\/CNCS109100","article-title":"Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era","volume":"5","author":"Del Sordo R","year":"2017","unstructured":"Del Sordo R, Brugnano R, Covarelli C, et al.. Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era. Clin Nephrol Case Stud. 2017, 5:70-7. 10.5414\/CNCS109100","journal-title":"Clin Nephrol Case Stud"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2017.06.022","article-title":"Membranous nephropathy and intrarenal extramedullary hematopoiesis in a patient with myelofibrosis","volume":"70","author":"Philipponnet C","year":"2017","unstructured":"Philipponnet C, Ronco P, Aniort J, Kemeny JL, Heng AE. Membranous nephropathy and intrarenal extramedullary hematopoiesis in a patient with myelofibrosis. Am J Kidney Dis. 2017, 70:874-7. 10.1053\/j.ajkd.2017.06.022","journal-title":"Am J Kidney Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-015-0121-6","article-title":"Primary myelofibrosis associated glomerulopathy: significant improvement after therapy with ruxolitinib","volume":"16","author":"Rajasekaran A","year":"2015","unstructured":"Rajasekaran A, Ngo TT, Abdelrahim M, Glass W, Podoll A, Verstovsek S, Abudayyeh A. Primary myelofibrosis associated glomerulopathy: significant improvement after therapy with ruxolitinib. BMC Nephrol. 2015, 16:121. 10.1186\/s12882-015-0121-6","journal-title":"BMC Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-013-0067-0","article-title":"Renal biopsy cases in myeloproliferative neoplasms (MPN)","volume":"2","author":"Fujita K","year":"2013","unstructured":"Fujita K, Hatta K. Renal biopsy cases in myeloproliferative neoplasms (MPN). CEN Case Rep. 2013, 2:215-21. 10.1007\/s13730-013-0067-0","journal-title":"CEN Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.147","article-title":"Myeloproliferative neoplasms cause glomerulopathy","volume":"80","author":"Said SM","year":"2011","unstructured":"Said SM, Leung N, Sethi S, et al.. Myeloproliferative neoplasms cause glomerulopathy. Kidney Int. 2011, 80:753-9. 10.1038\/ki.2011.147","journal-title":"Kidney Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-005-0391-6","article-title":"Focal segmental glomerulosclerosis associated with essential thrombocythemia","volume":"10","author":"Haraguchi K","year":"2006","unstructured":"Haraguchi K, Shimura H, Ogata R, et al.. Focal segmental glomerulosclerosis associated with essential thrombocythemia. Clin Exp Nephrol. 2006, 10:74-7. 10.1007\/s10157-005-0391-6","journal-title":"Clin Exp Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509054751","article-title":"TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders","volume":"20","author":"Martyr\u00e9 MC","year":"1995","unstructured":"Martyr\u00e9 MC. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Leuk Lymphoma. 1995, 20:39-44. 10.3109\/10428199509054751","journal-title":"Leuk Lymphoma"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb07952.x","article-title":"Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia","volume":"77","author":"Martyr\u00e9 MC","year":"1991","unstructured":"Martyr\u00e9 MC, Magdelenat H, Bryckaert MC, Laine-Bidron C, Calvo F. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia. Br J Haematol. 1991, 77:80-6. 10.1111\/j.1365-2141.1991.tb07952.x","journal-title":"Br J Haematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/284706","article-title":"Impact of inflammation on myeloproliferative neoplasm symptom development","volume":"2015","author":"Geyer HL","year":"2015","unstructured":"Geyer HL, Dueck AC, Scherber RM, Mesa RA. Impact of inflammation on myeloproliferative neoplasm symptom development. Mediators Inflamm. 2015, 2015:284706. 10.1155\/2015\/284706","journal-title":"Mediators Inflamm"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100711","article-title":"Role of inflammation in the biology of myeloproliferative neoplasms","volume":"42","author":"Koschmieder S","year":"2020","unstructured":"Koschmieder S, Chatain N. Role of inflammation in the biology of myeloproliferative neoplasms. Blood Rev. 2020, 42:100711. 10.1016\/j.blre.2020.100711","journal-title":"Blood Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/his.14282","article-title":"Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome\/myeloproliferative neoplasms","volume":"78","author":"B\u00fcttner-Herold M","year":"2021","unstructured":"B\u00fcttner-Herold M, Sticht C, Wiech T, Porubsky S. Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome\/myeloproliferative neoplasms. Histopathology. 2021, 78:738-48. 10.1111\/his.14282","journal-title":"Histopathology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.7.2873","article-title":"Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor","volume":"89","author":"Doi T","year":"1992","unstructured":"Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci U S A. 1992, 89:2873-7. 10.1073\/pnas.89.7.2873","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007050532","article-title":"A new look at platelet-derived growth factor in renal disease","volume":"19","author":"Floege J","year":"2008","unstructured":"Floege J, Eitner F, Alpers CE. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol. 2008, 19:12-23. 10.1681\/ASN.2007050532","journal-title":"J Am Soc Nephrol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.15.6560","article-title":"Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat","volume":"88","author":"Iida H","year":"1991","unstructured":"Iida H, Seifert R, Alpers CE, et al.. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A. 1991, 88:6560-4. 10.1073\/pnas.88.15.6560","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2006.00553.x","article-title":"Aldose reductase regulates TGF-beta1-induced production of fibronectin and type IV collagen in cultured rat mesangial cells","volume":"11","author":"Jiang T","year":"2006","unstructured":"Jiang T, Che Q, Lin Y, Li H, Zhang N. Aldose reductase regulates TGF-beta1-induced production of fibronectin and type IV collagen in cultured rat mesangial cells. Nephrology (Carlton). 2006, 11:105-12. 10.1111\/j.1440-1797.2006.00553.x","journal-title":"Nephrology (Carlton)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114731","article-title":"Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix","volume":"86","author":"Okuda S","year":"1990","unstructured":"Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest. 1990, 86:453-62. 10.1172\/JCI114731","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.2174\/0929867311320090004","article-title":"JAK inhibitors: pharmacology and clinical activity in chronic myeloprolipherative neoplasms","volume":"20","author":"Trelinski J","year":"2013","unstructured":"Trelinski J, Robak T. JAK inhibitors: pharmacology and clinical activity in chronic myeloprolipherative neoplasms. Curr Med Chem. 2013, 20:1147-61.","journal-title":"Curr Med Chem"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/114578-myeloproliferative-neoplasm-and-myelodysplastic-syndrome-associated-renal-disease-a-histopathological-report-of-two-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:17Z","timestamp":1707507857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/114578-myeloproliferative-neoplasm-and-myelodysplastic-syndrome-associated-renal-disease-a-histopathological-report-of-two-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,10]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.32388","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,10]]}}}